Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;36(4):609-625.
doi: 10.1007/s11011-021-00670-2. Epub 2021 Jan 28.

The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway

Piniel Alphayo Kambey  1 , Ma Chengcheng  1 , Guo Xiaoxiao  1 , Ayanlaja Abiola Abdulrahman  1 , Kouminin Kanwore  1 , Iqra Nadeem  1 , Wu Jiao  1 , Dianshuai Gao  2
Affiliations

The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway

Piniel Alphayo Kambey et al. Metab Brain Dis. 2021 Apr.

Abstract

Recent studies implicate the defects or altered expression of the orphan nuclear receptor Nurr1 gene in the substantia nigra in Parkinson's disease pathogenesis. In an attempt to corroborate the treatment-modifying disease that would replicate the effect of Nurr1, it has been found that amodiaquine and Nurr1 had the same chemical scaffolding, indicating a crucial structure-activity relationship. Interestingly, amodiaquine stimulate the transcriptional function of Nurr1 by physical interaction with its ligand-binding domain (LBD). However, the signaling route by which Nurr1 is activated by amodiaquine to cause the protective effect remains to be elucidated. We first demonstrated that amodiaquine treatment ameliorated behavioural deficits in 6-OHDA Parkinson's disease mouse model, and it promoted dopaminergic neurons protection signified by Tyrosine hydroxylase (TH) and dopamine transporter (DAT) mRNA; Tyrosine hydroxylase (TH) protein expression level and the immunoreactivity in the substantia nigra compacta. Subsequently, we used inhibitors to ascertain the effect of amodiaquine on Akt and P38 Mapk as crucial signaling pathways for neuroprotection. Wortmannin (Akt Inhibitor) induced a significant reduction of Akt mRNA; however, there was no statistical difference between the amodiaquine-treated group and the control group suggesting that amodiaquine may not be the active stimulant of Akt. Western blot analysis confirmed that the phosphorylated Akt decreased significantly in the amodiaquine group compared to the control group. In the same vein, we found that amodiaquine substantially increased the level of phosphorylated P38 Mapk. When P38 Mapk inhibited by SB203580 (P38-Mapk Inhibitor), the total P38 Mapk but not the phosphorylated P38 Mapk decreased significantly, while tyrosine hydroxylase significantly increased. These results collectively suggest that amodiaquine can augment tyrosine hydroxylase expression via phosphorylated P38 Mapk while negatively regulating the phosphorylated Akt in protein expression.

Keywords: Akt; Amodiaquine; Dopaminergic neuron; Nuclear receptor-related one (Nurr1); P38-Mapk; Parkinson’s disease.

PubMed Disclaimer

References

    1. Aguiar AS Jr, Moreira EL, Hoeller AA, Oliveira PA, Cordova FM, Glaser V et al (2013) Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice. Neuroscience 243:46–53. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23558088 . https://doi.org/10.1016/j.neuroscience.2013.03.039 - DOI - PubMed
    1. Aoi M, Date I, Tomita S, Ohmoto T (2000a) The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Neurosci Res 36(4):319–325. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10771110 . https://doi.org/10.1016/s0168-0102(00)00097-3 - DOI - PubMed
    1. Aoi M, Date I, Tomita S, Ohmoto T (2000b) Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Neurol Res 22(8):832–836. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11149247 . https://doi.org/10.1080/01616412.2000.11740761 - DOI - PubMed
    1. Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M et al (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Prog Neurobiol 132:96–168. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26209473 . https://doi.org/10.1016/j.pneurobio.2015.07.002 - DOI - PubMed
    1. Bohush A, Niewiadomska G, Filipek A (2018). Role of mitogen activated protein kinase signaling in Parkinson's disease. Int J Mol Sci, 19(10). Retrieved from <Go to ISI>://WOS:000448951000128. https://doi.org/10.3390/ijms19102973

Publication types

MeSH terms

LinkOut - more resources